CClinicalTrials.gg
RecruitingNCT05713617PODERUpdated Jul 26, 2024

PODER Familiar: Health Promotion for Latino Families of Children With IDD

An interventional study of PODER Familiar in Health-Related Behavior, Quality of Life and Psychological Distress, sponsored by University of Texas at Austin. Recruiting at 2 sites in United States. Open to participants aged 6 Years to 100 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-07-26.

Sponsored by University of Texas at Austin · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Primary completion was expected by Sep 2024, 2 years ago, but the record still lists the study as recruiting.
  • Started Jan 2023; still recruiting 3 years 8 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
6 Years to 100 Years
Sex
All
01

Study summary

The goal of this clinical trial is to test a culturally tailored health promotion intervention for children with IDD and their families. First investigators will conduct a single group design pilot study of a health promotion intervention, followed by second, a small-scale randomized control trial (RCT). of the intervention with Latino parents of children with intellectual and developmental disabilities (IDD) in the Chicago, Illinois and Austin, Texas areas. The following research questions will be addressed:

Question 1: What is the appropriate content, dosage, and delivery method of the intervention?

Question 2: What is the feasibility and acceptability of the intervention?

Question 3: Do participants improve between pre and post-test on outcome measures both in the one group design and compared to the control group in the RCT?

Parents will receive 10 weekly remote sessions on health promotion content delivered by parent mentors called promotoras. Parents and children will attend 3 multi-family group workshops in-person that will provide demonstrations and interactive activities.

Read the detailed description

PODER Familiar will consist of 10 weekly remote one-on-one sessions with the parent and the promotora, and 3 monthly multi-group family sessions to be held in-person. The weekly remote sessions will be conducted on a video-chat platform The multi-group family sessions will be held at a community friendly location (a community center or space at a community organization) in which 3 to 5 families will attend. Family units will consist of the parent and child with IDD and other family members who wish to attend (other parent, siblings, etc.). Group sessions will reinforce content covered in the curriculum through interactive activities and demonstrations.

The promotoras who deliver the weekly sessions will be bilingual and will also be parents of children with IDD. They will offer the sessions in the language of preference of the participant. Promotoras will receive 15 hours of training on content and procedures. Individual sessions will be audio-recorded and reviewed for fidelity, training and consistency.

The group sessions will be conducted by the PIs and graduate students at each site. Groups will be conducted in Spanish and English.

Phase I: Piloting the Intervention (Research Questions 1 \&2) Phase I will consist of a one group pre and post-test design with no control group.

Sample and Recruitment. Thirty Latino families will be recruited for the pilot study (15 in Chicago, and 15 in Austin). Community organizations will help recruit eligible families using an informational flyer about the study and an accompanying verbal recruitment script. All recruitment materials will be translated to Spanish. Families who express interest in participation will be contacted by a trained bilingual research assistant to complete consent forms and to schedule the baseline assessment. After a cohort of 15 families has been recruited at each site, the pilot intervention will be scheduled.

Data Source/Data Collection. Parents/caregivers will complete objective and self-report assessments at baseline and post-intervention follow-up through telephone or video chat interviews with trained students. Two interviews will be conducted at baseline and two at follow-up to collect the full battery of measures.

At baseline and again at follow-up, participants will be instructed to wear accelerometers (ActiGraph GT3XP-BTLE 2GB) for at least 12 hours over seven consecutive days. The accelerometers will be mailed to the participant after the first baseline and follow-up interview with a return mail postage paid envelope.

Participants will wear the monitor for at least one week and a 15-second time interval will be used. The total minutes per day in moderate to vigorous physical activity and sedentary activity will be computed with Actilife Software Version 6.13 (Actigraph Corp, Pensacola, FL). investigators will use previously established cut points for physical activity, which provide acceptable classification accuracy for all levels of physical activity intensity among children of all ages.

Acceptability measures include: (1) Satisfaction with the intervention, which will be evaluated using a survey to be completed by parents/caregivers after each of the six family group workshop sessions and after the full 12-week intervention. Satisfaction survey will include questions about accessibility and adequacy of participation of youth with IDD. 2) Engagement in the intervention, which will be assessed by study staff rating participants (caregivers and children) on behaviors such as being present for the whole session, verbal interaction in group sessions, and frequency of contact with promotoras. Special attention will be given to the engagement of youth with IDD in all aspects of the group sessions. Feasibility measures include (1) number of families approached for recruitment and number enrolled, (2) reasons for declining, (3) attendance at family group sessions based on attendance logs; participants who miss sessions will be called to inquire about barriers to attendance, (4) retention at post-intervention, (5) completion of the 4-month follow-up, and (6) intervention fidelity. To monitor fidelity, investigators will audio record group and one-on-one sessions. A bilingual research assistant will review recordings against a fidelity checklist to ensure adherence to active ingredients of the intervention. If the session score is \<80% on the fidelity checklist, group facilitators and promotoras will be notified to review the intervention content.

Phase II: Exploratory RCT (Research Question 3) The intervention will be modified using feedback from the single arm study, and will be tested using a randomly allocated two-group time series design. This will be an exploratory study to assess preliminary efficacy of the intervention. Investigators will submit an amendment with details on this phase of the study before implementing this phase.

Data Analysis

Phase I: Piloting the Intervention Descriptive statistics will be used to summarize feasibility and acceptability measures. To generate estimates for future trials, investigators will compute group-specific means and standard deviations for outcome measures. Investigators will used student t tests to examine differences between baseline and follow-up on outcome measures.

Qualitative data from focus groups will be tape-recorded. Recordings will be transcribed verbatim in Spanish and translated to English. Transcripts will be imported into Atlas.ti Qualitative Data Analysis Software. English and Spanish transcripts will be reviewed in their original languages using a mixed approach, which combines inductive reasoning with predetermined coding strategies. Using this approach, transcripts will be first reviewed in entirety to understand the scope of the data. Next, investigators will review the transcripts line-by-line and organize data using an a priori coding scheme, which will include (1) conceptual codes (e.g. acceptability of intervention); (2) participant perspective codes (e.g. satisfaction with intervention); (3) participant characteristic codes; (4) intervention-specific codes; and (4) relationship codes (which identify links between other codes). The two reviewers will share emerging codes and a coding dictionary will be developed to guide more specific application of codes. The coding scheme will be sequentially refined until investigators achieve theoretical saturation. Analyzing data in English and Spanish will allow both etic (outsider) and emic (insider) perspectives to emerge. Focus group data will be synthesized, and a summary of the synthesis will be shared with participating families. The researchers will then conduct a member-checking interview with at least three caregiver participants to ensure credibility of the analysis. Inter-coder reliability will be calculated between coders. A high inter-coder reliability may indicate strong coding methods and operational definitions of terms.

02

Conditions studied

  • Health-Related Behavior
  • Quality of Life
  • Psychological Distress
  • Diet, Healthy
  • Physical Inactivity

Keywords

  • healthy lifestyle
  • Latino families
  • developmental disabilities
03

In context

Developmental Disabilities

285 studies on the registry are indexed under Developmental Disabilities; 64 are open to participants now.

This study's planned enrollment of 90 is above the median of 60 across 199 interventional studies indexed under Developmental Disabilities.

Browse Developmental Disabilities studies →

Lead sponsor

University of Texas at Austin is the lead sponsor of 319 studies on the registry; 78 are open to participants now.

Of its 10 completed or terminated interventional studies of FDA-regulated products, 5 (50%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

Parent/Caregiver

  • identify as parent or primary family caregiver
  • 18 years of age or older
  • Identify as Latino/a or of Latin American Descent
  • have a child with IDD between 6 and 17 years of age Child with IDD
  • between 6 and 17 years old
  • the child has a diagnosis of autism spectrum disorder, Down syndrome or intellectual disability

Exclusion criteria

Exclusion Criteria:

  • Child uses mobility aid
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
90 participants (estimated)

Study arms

  • Experimental
    Intervention group

    Participants will receive 10 remote sessions with the curriculum with a promotora, and 3 in-person group workshops.

    Behavioral: PODER Familiar

  • No intervention
    control group

    Participants will receive community services as usual

Interventions

  • BehavioralPODER Familiar

    Educational intervention designed to improve healthy behaviors of families of children with intellectual and developmental disabilities.

06

What researchers measure

Primary outcomes

  1. Change from baseline parent Body Mass Index at 4 months

    Weight and height measurement

    Time frame: from baseline to 4 months

  2. Change from baseline parent health-related quality of life at 4 months

    PROMIS Global Health (parent); minimum 9 maximum 45, higher better

    Time frame: from baseline to 4 months

  3. Change from baseline parent psychological distress at 4 months

    Center for Epidemiological Studies - Depression, minimum 0 maximum 60, higher worse

    Time frame: from baseline to 4 months

  4. Change from baseline child body mass index percentile at 4 months

    weight and height measurement

    Time frame: from baseline to 4 months

  5. Change from baseline child health related quality of life at 4 months

    PROMIS Pediatric Scale Global, minimum 7, maximum 35, higher better

    Time frame: from baseline to 4 months

Secondary outcomes

  1. Change from baseline parent physical activity at 4 months

    ActiGraph accelerometer, measures 4 categories: sedentary, light, moderate, vigorous PA

    Time frame: from baseline to 4 months

  2. Change from baseline parent dietary Intake at 4 months

    Dietary Screener Questionnaire (DSQ) intake of fruit, vegetables, dairy, sugars, \& whole grains

    Time frame: from baseline to 4 months

  3. Change from baseline child physical activity at 4 months

    ActiGraph accelerometer, measures 4 categories: sedentary, light, moderate, vigorous PA

    Time frame: from baseline to 4 months

  4. Change from baseline child dietary Intake at 4 months

    Dietary Screener Questionnaire (DSQ) intake of fruit, vegetables, dairy, sugars, \& grains

    Time frame: from baseline to 4 months

07

Study locations

2 of 2 sites recruiting
  • University of Illinois at Chicago
    Chicago, Illinois 60612, United States
    Recruiting
  • Steve Hicks School of Social Work, University of Texas at Austin
    Austin, Texas 78712, United States
    • Desiree Pacheco · Contact · desiree.pacheco@austin.utexas.edu · 512-471-1937
    • Sandy Magana · Contact · smagana@austin.utexas.edu · 512-232-9216
    • Sandy Magana, PhD · Principal investigator
    • Sandra Vanegas, PhD · Sub investigator
    • Deborah Parra-Medina, PhD · Principal investigator
    • Yolanda Suarez-Balcazar, PhD · Sub investigator
    • Mansha Mirza, PhD · Sub investigator
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes — Our funder requires that we share de-identified data with the Inter-University Consortium for Political and Social Research (ICPSR) no later than 24 months from the completion of the study end date. We will deidentify all data and submit the database to ICPSR according to their specifications.

Supporting information: Study protocol, Sap, Icf

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 26, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05713617
Lead sponsor
University of Texas at Austin
Collaborators
University of Illinois at Chicago
Responsible party
Sandy Magaña (Professor, University of Texas at Austin) — Principal investigator
First posted
Feb 6, 2023
Start date
Jan 17, 2023
Primary completion
Sep 30, 2024 (estimated)
Completion
Sep 30, 2024 (estimated)
Last update
Jul 26, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion